UNICA IRIS Institutional Research Information System

MACCIO', ANTONIO PIETRO MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 130.100
NA - Nord America 15.070
AS - Asia 5.783
SA - Sud America 960
Continente sconosciuto - Info sul continente non disponibili 521
AF - Africa 168
OC - Oceania 6
AN - Antartide 2
Totale 152.610
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 126.577
US - Stati Uniti d'America 14.746
SG - Singapore 2.117
CN - Cina 1.993
UA - Ucraina 918
SE - Svezia 734
BR - Brasile 709
VN - Vietnam 554
DE - Germania 452
FI - Finlandia 373
GB - Regno Unito 352
FR - Francia 300
HK - Hong Kong 265
IN - India 179
CA - Canada 167
KR - Corea 159
BD - Bangladesh 110
AR - Argentina 97
RU - Federazione Russa 77
NL - Olanda 62
ID - Indonesia 51
MX - Messico 47
JP - Giappone 40
PK - Pakistan 39
TR - Turchia 39
ZA - Sudafrica 39
EC - Ecuador 38
IQ - Iraq 38
PL - Polonia 35
AT - Austria 33
CO - Colombia 33
PH - Filippine 31
IE - Irlanda 29
MA - Marocco 28
ES - Italia 27
UZ - Uzbekistan 22
SA - Arabia Saudita 21
VE - Venezuela 21
JM - Giamaica 20
LT - Lituania 20
CL - Cile 19
EG - Egitto 19
IR - Iran 18
TT - Trinidad e Tobago 17
CR - Costa Rica 16
CH - Svizzera 15
KE - Kenya 15
PE - Perù 15
TN - Tunisia 15
BE - Belgio 14
SC - Seychelles 13
TH - Thailandia 13
EE - Estonia 11
IL - Israele 10
MY - Malesia 10
PY - Paraguay 10
RO - Romania 10
UY - Uruguay 10
DK - Danimarca 9
DZ - Algeria 9
EU - Europa 9
JO - Giordania 8
KZ - Kazakistan 8
NI - Nicaragua 8
PR - Porto Rico 8
AL - Albania 7
CZ - Repubblica Ceca 7
HN - Honduras 7
NP - Nepal 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
RS - Serbia 6
AU - Australia 5
BZ - Belize 5
HU - Ungheria 5
LB - Libano 5
LK - Sri Lanka 5
OM - Oman 5
PS - Palestinian Territory 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
BS - Bahamas 4
HR - Croazia 4
KW - Kuwait 4
PT - Portogallo 4
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
ET - Etiopia 3
GR - Grecia 3
MU - Mauritius 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
AQ - Antartide 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
Totale 152.055
Salva come PNG Salva come JPEG
Città #
Cagliari 122.427
Uta 3.362
Ashburn 1.594
Fairfield 1.282
Woodbridge 1.098
Singapore 1.069
San Jose 871
Houston 775
Dallas 711
Chandler 628
Boardman 603
Nyköping 544
Seattle 541
Ann Arbor 536
Jacksonville 523
Wilmington 506
Cambridge 422
Beijing 357
Council Bluffs 298
New York 271
Hong Kong 242
Los Angeles 235
Helsinki 227
Dearborn 224
Santa Clara 215
Ho Chi Minh City 180
Hefei 177
Lauterbourg 168
Nanjing 167
Boston 164
Seoul 136
The Dalles 125
Hanoi 114
Buffalo 113
San Diego 93
Guangzhou 91
Milan 91
Shanghai 86
São Paulo 71
Dong Ket 68
London 66
Toronto 63
Menlo Park 57
Shenyang 53
Chicago 52
Phoenix 51
Rome 51
Changsha 43
Redwood City 43
Nanchang 42
Redondo Beach 42
Tianjin 42
Atlanta 41
Columbus 40
Frankfurt am Main 40
Orem 37
Nuremberg 36
Chennai 34
Jinan 33
Hebei 32
Jiaxing 32
Tokyo 32
Pune 30
Norwalk 29
Princeton 29
Verona 28
Dundalk 27
Rio de Janeiro 24
Warsaw 24
Montreal 23
Orange 23
San Francisco 23
Denver 22
Mountain View 22
Munich 22
Haiphong 21
Zhengzhou 21
North Bergen 20
Vienna 20
Baghdad 19
Hangzhou 19
Johannesburg 19
Brooklyn 18
Amsterdam 17
Da Nang 17
Tashkent 17
Auburn Hills 16
Charlotte 16
Philadelphia 16
Kingston 15
Mumbai 15
Washington 15
Belo Horizonte 14
Buenos Aires 14
Nairobi 14
Brussels 13
Detroit 13
Manchester 13
Quito 13
San José 13
Totale 143.101
Salva come PNG Salva come JPEG
Nome #
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.384
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.586
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.492
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.446
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 2.276
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.217
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.213
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 2.073
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 2.047
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.991
Advances in pharmacologic strategies for cancer cachexia 1.912
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.910
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.871
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.813
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.803
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.799
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.794
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.754
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.743
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.739
Successful laparoscopic management of a giant ovarian cyst 1.735
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.734
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.728
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.721
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.712
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.675
Surprising results of a supportive integrated therapy in myelofibrosis 1.624
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.597
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.594
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.579
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.552
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.529
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.503
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.483
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.431
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.365
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.339
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.232
Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer 1.181
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.165
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.088
Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy 1.025
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 1.013
null 998
Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer 975
Blocking inflammation to improve immunotherapy of advanced cancer 961
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients 954
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report 936
Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients 927
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review 890
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 883
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer 879
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 877
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 860
Three cases of laparoscopic myomectomy performed during pregnancy for pedunculated uterine myomas 855
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 843
null 819
Successful pregnancy following myomectomy of a giant uterine myoma: role of a combined surgical approach 815
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 808
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 803
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 800
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 799
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 798
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 793
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 782
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 781
Experimental drugs for chemotherapy-and cancer-related anemia 772
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 765
Current medications for cancer cachexia 740
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 724
Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series 717
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 712
null 709
Novel technique of extracorporeal intrauterine morcellation after total laparoscopic hysterectomy: Three emblematic case reports 709
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 687
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 671
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation 651
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 649
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 644
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 636
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 633
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 632
Managing cancer-related anorexia/cachexia 628
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 619
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 618
Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer 610
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 609
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 607
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 604
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 603
Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease 603
Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report and Literature Review 599
The mechanism of cancer cell death by PARP inhibitors goes beyond DNA damage alone 595
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report 589
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 583
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 583
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life 581
Cachexia and oxidative stress in cancer: an innovative therapeutic management 579
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 579
Multitargeted treatment of cancer cachexia 577
Totale 117.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.085 0 0 0 0 721 447 469 481 605 537 702 1.123
2022/202313.193 1.054 1.398 1.170 1.002 925 1.439 747 1.423 965 978 1.353 739
2023/202415.777 994 639 532 1.061 1.520 2.821 2.198 1.004 749 1.070 1.661 1.528
2024/202519.801 2.461 3.737 3.090 3.232 1.625 2.406 1.441 195 420 384 400 410
2025/202610.675 593 534 1.406 998 745 650 1.876 429 870 1.514 693 367
2026/20273.189 145 646 1.001 1.188 209 0 0 0 0 0 0 0
Totale 152.610